Menu Back toEffective-Management-of-Internal-Stakeholders-and-External-Strategic-Partners

DIA 2018 Global Annual Meeting

The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.

Effective Management of Internal Stakeholders and External Strategic Partners from Multiple Perspectives: Non-Profit, CRO, and Pharmaceutical Industry

    Session Chair(s)
      Jing  Li, MBA, MS, PMP

      Jing Li, MBA, MS, PMP

      • Head of Program Management Office
      • Castle Creek Pharmaceuticals, United States
    Drug development has become an increasingly complex process due to rising costs, increased regulations, and the need to collaborate with essential internal and external stakeholders. Companies are embracing strategies to mitigate the risks of these costly and time sensitive development programs. This has resulted in an increasing number of companies in-licensing products and outsourcing development activities. Therefore, effective stakeholder management is an essential component of any successful drug development project. This forum will include three panelists who are experts in managing the collaborations and strategies for the biotech/pharmaceutical drug development process. This includes stakeholders such as business partners, non-profit consortiums, academia, key opinion leaders, and patient advocacy groups. Panelists will share their experiences and through case studies demonstrate some of the challenges they face in their individual unique settings. These challenges include how each business segment (advocacy, CRO, and medical affairs), define key stakeholders and how they developed plans to manage expectations and achieve project goals within set timeline and budget parameters.
    Learning Objective : Define stakeholders and recognize different levels of stakeholders; Identify key stakeholders and stakeholders in various settings from different perspectives; Recognize the similarities and differences of stakeholders in different settings; Identify risks and mitigation strategies; Develop a stakeholder management plan.
      Debora  Merrill, MBA

      Stakeholder Management: From Non-Profit and Industry/Academic/Government Consortium

      Debora Merrill, MBA

      • Vice President, COPD Biomarker Qualification Consortium
      • COPD Foundation, United States
      Steven  Innaimo, MS

      Stakeholder Management: From CRO Perspective

      Steven Innaimo, MS

      • Head, Program Management Office
      • Covance, United States
      Stephen  Apple, MD

      Stakeholder Management: From Sponsor Medical Affairs Perspective

      Stephen Apple, MD

      • Senior Medical Director
      • Mitsubishi Tanabe Pharma America, United States